As healthcare providers, our understanding of neurodegenerative disorders is continually evolving, and Parkinson's Disease (PD) is no exception. This article provides a comprehensive overview of PD, its pathophysiology, clinical manifestations, diagnosis, and treatment options.
PD is primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to an imbalance in the dopaminergic and cholinergic systems. The accumulation of α-synuclein, forming Lewy bodies, is a significant hallmark of the disease.
PD presents a range of motor symptoms such as bradykinesia, rigidity, and tremors. Non-motor symptoms like cognitive impairment, mood disorders, and autonomic dysfunction are also prevalent. The disease progression varies significantly among patients.
Diagnosis is primarily clinical, based on patient history and neurological examination. Currently, no definitive diagnostic test exists for PD; however, neuroimaging techniques like DaTSCAN can support the diagnosis.
Treatment for PD is symptomatic and aims to manage motor and non-motor symptoms. Levodopa remains the most effective treatment for motor symptoms. Deep Brain Stimulation (DBS) is another treatment modality for patients with advanced PD.
Research is ongoing to develop disease-modifying therapies for PD. These include neuroprotective agents, immunotherapies targeting α-synuclein, and regenerative therapies like stem cell transplantation.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. Understanding its pathophysiology, clinical manifestations, and treatment options is crucial for providing comprehensive care. As medical professionals, we must stay abreast of the latest research to effectively manage and potentially alter the course of this debilitating disease.
1.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
2.
Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection
3.
Implant-based reconstruction linked to increased risk of breast lymphomas
4.
Adult overdose deaths on the rise
5.
Simpler Screening Criteria Could Catch More Lung Cancers
1.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
2.
Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options
3.
Patient Management for Bone Marrow Functional Recovery Pathways
4.
Engineered Red Blood Cell Therapeutics: Emerging Applications
5.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation